Enliven Therapeutics Inc. (ELVN) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $25,131,507.81
Most recent insider trade:
- May 14, 2024
Most active insider trader:
- Anish Patel
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 14, 2024 | COO | 1,107 | $25.00 | Sell | $27,675.00 | |
May 9, 2024 | COO | 260 | $25.06 | Sell | $6,515.60 | |
May 6, 2024 | COO | 4,875 | $22.72 | Sell | $110,760.00 | |
May 3, 2024 | CFO | 1,000 | $22.50 | Sell | $22,500.00 | |
April 29, 2024 | insider | 12,000 | $17.92 | Sell | $215,040.00 | |
April 29, 2024 | CFO | 3,250 | $16.97 | Sell | $55,152.50 | |
April 25, 2024 | CEO | 12,000 | $16.89 | Sell | $202,680.00 | |
April 15, 2024 | Director | 1,270 | $19.99 | Sell | $25,387.30 | |
April 11, 2024 | CEO | 47,709 | $25.04 | Sell | $1,194,633.36 | |
April 11, 2024 | COO | 17,500 | $25.03 | Sell | $438,025.00 | |
April 11, 2024 | CFO | 14,000 | $24.72 | Sell | $346,080.00 | |
April 11, 2024 | insider | 30,000 | $25.04 | Sell | $751,200.00 | |
April 11, 2024 | Director | 53,400 | $23.95 | Sell | $1,278,930.00 | |
April 8, 2024 | COO | 4,875 | $18.60 | Sell | $90,675.00 | |
April 4, 2024 | Director | 3,485 | $19.15 | Sell | $66,737.75 | |
April 1, 2024 | Director | 3,237 | $19.08 | Sell | $61,761.96 | |
April 1, 2024 | insider | 12,000 | $18.60 | Sell | $223,200.00 | |
March 27, 2024 | CFO | 3,250 | $18.25 | Sell | $59,312.50 | |
March 25, 2024 | CEO | 12,000 | $17.56 | Sell | $210,720.00 | |
March 19, 2024 | Director | 1,270 | $14.50 | Sell | $18,415.00 | |
March 6, 2024 | COO | 4,875 | $15.64 | Sell | $76,245.00 | |
Feb. 29, 2024 | insider | 12,000 | $16.42 | Sell | $197,040.00 | |
Feb. 27, 2024 | CFO | 3,250 | $16.97 | Sell | $55,152.50 | |
Feb. 15, 2024 | Director | 1,270 | $17.42 | Sell | $22,123.40 | |
Feb. 6, 2024 | COO | 4,875 | $15.11 | Sell | $73,661.25 | |
Jan. 31, 2024 | Major Shareholder | 500,000 | $15.00 | Sell | $7,500,000.00 | |
Jan. 30, 2024 | Director | 1,270 | $16.41 | Sell | $20,840.70 | |
Jan. 29, 2024 | CFO | 3,250 | $15.81 | Sell | $51,382.50 | |
Jan. 29, 2024 | insider | 12,000 | $15.85 | Sell | $190,200.00 | |
Jan. 25, 2024 | CEO | 12,000 | $15.69 | Sell | $188,280.00 | |
Jan. 22, 2024 | COO | 4,875 | $15.13 | Sell | $73,758.75 | |
Jan. 2, 2024 | COO | 11,000 | $15.00 | Sell | $165,000.00 | |
Jan. 2, 2024 | CFO | 9,383 | $15.01 | Sell | $140,838.83 | |
Dec. 26, 2023 | COO | 102 | $15.01 | Sell | $1,531.02 | |
Dec. 26, 2023 | CEO | 12,000 | $14.64 | Sell | $175,680.00 | |
Dec. 26, 2023 | CFO | 100 | $15.00 | Sell | $1,500.00 | |
Dec. 22, 2023 | CEO | 8,175 | $13.05 | Sell | $106,683.75 | |
Dec. 22, 2023 | COO | 983 | $15.03 | Sell | $14,774.49 | |
Dec. 22, 2023 | CFO | 1,030 | $15.07 | Sell | $15,522.10 | |
Dec. 21, 2023 | insider | 20 | $13.00 | Sell | $260.00 | |
Dec. 21, 2023 | Director | 7 | $13.00 | Sell | $91.00 | |
Dec. 20, 2023 | CEO | 7,779 | $13.01 | Sell | $101,204.79 | |
Dec. 19, 2023 | insider | 200 | $13.00 | Sell | $2,600.00 | |
Dec. 19, 2023 | Director | 255 | $13.00 | Sell | $3,315.00 | |
Nov. 3, 2023 | insider | 8,546 | $13.08 | Sell | $111,781.68 | |
Nov. 3, 2023 | CEO | 8,026 | $13.08 | Sell | $104,980.08 | |
Sept. 29, 2023 | insider | 12,000 | $13.62 | Sell | $163,440.00 | |
Sept. 26, 2023 | Major Shareholder | 197,500 | $15.00 | Sell | $2,962,500.00 | |
Sept. 25, 2023 | CEO | 12,000 | $13.81 | Sell | $165,720.00 | |
Aug. 24, 2023 | Major Shareholder | 440,000 | $16.00 | Sell | $7,040,000.00 |
First«1 of 1»Last
Insiders are selling Enliven Therapeutics Inc. stock.
The insider traders at Enliven Therapeutics Inc. are: Anish Patel, Benjamin Hohl, Joseph P. Lyssikatos, Samuel Kintz, Richard A Heyman, Rahul D Ballal, and 5Am Partners Vi, Llc
The most active insider trader at Enliven Therapeutics Inc. is Anish Patel with 11 trades.
5Am Partners Vi, Llc has sold the most Enliven Therapeutics Inc. stock with a total value of $25,002,500.00.
The most recent insider trade for Enliven Therapeutics Inc. was on May 14, 2024.
The single biggest insider sell for Enliven Therapeutics Inc. was from 5Am Partners Vi, Llc with a total value of $7,500,000.00 on Jan. 31, 2024.